Mineralys Therapeutics, Inc.(MLYS)
$15.33-0.17 (-1.10%)
MLYS
Mineralys Therapeutics, Inc. financials statements
$15.33
At close:-0.17 (-1.10%)
Want to see MLYS full AI Analyst Report?
Mineralys Therapeutics, Inc. (MLYS) Income Statement
614 Followers
Mineralys Therapeutics, Inc. Income Statement
Last quarter (Q3 2026), Mineralys Therapeutics, Inc.'s total revenue was $0.00. In Q3, Mineralys Therapeutics, Inc.'s net income was $-57.33M. See Mineralys Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 170.60M | $ 192.40M | $ 84.66M | $ 31.48M | $ 18.73M | |
| Depreciation and Amortization | $ 59.00K | $ 43.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -154.59M | $ -177.77M | $ -71.90M | $ -28.12M | $ -19.38M | |
| $ -170.60M | $ -192.40M | $ -84.66M | $ -31.48M | $ -18.73M | |
| $ 15.95M | $ 14.59M | $ 12.76M | $ 1.68M | $ -683.00K | |
| $ -154.65M | $ -177.81M | $ -71.90M | $ -29.80M | $ -19.41M | |
| $ -154.65M | $ -177.81M | $ -71.90M | $ -29.80M | $ -19.41M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.29 | $ -3.66 | $ -1.99 | $ -5.77 | $ -3.89 |
| Diluted EPS | $ -2.29 | $ -3.66 | $ -1.99 | $ -5.77 | $ -3.89 |
| Weighted Average Shares Outstanding | 67.66M | 48.54M | 36.19M | 5.17M | 4.98M |
| Weighted Average Shares Outstanding (Diluted) | 67.66M | 48.54M | 36.19M | 5.17M | 4.98M |
Currency in USD
